Yingxia Liu

Prof. Dr. Yingxia Liu

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2020 in JAMA
Verified
Journal Article
Open access
PDF file
CSChenguang Shen
Chenguang Shen
ZWZhaoqin Wang
Zhaoqin Wang
FZFang Zhao
Fang Zhao
YYYang Yang
Yang Yang
JLJinxiu Li
Jinxiu Li
LLLei Liu
Lei Liu
The epidemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China, has rapidly spread worldwide.1 As of March 24, 2020, China had reported 81 767 cases with 3281 deaths, and the World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic. As of March 18, 2020, cases were reported in approximately 195 countries.2

9 February 2020 in Science China Life Sciences
Verified
Journal Article
Open access
PDF file
YLYingxia Liu
Yingxia Liu
YYYang Yang
Yang Yang
CZCong Zhang
Cong Zhang
FHFengming Huang
Fengming Huang
FWFuxiang Wang
Fuxiang Wang
LLLei Liu
Lei Liu
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province, and rapidly spread to many provinces in China as well as other countries. Here we report the epidemiological, clinical, laboratory, and radiological characteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China. All 12 cases of the 2019-nCoV-infected patients developed pneumonia and half of them developed acute respiratory distress syndrome (ARDS). The most common laboratory abnormalities were hypoalbuminemia, lymphopenia, decreased percentage of lymphocytes (LYM) and neutrophils (NEU), elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH), and decreased CD8 count. The viral load of 2019-nCoV detected from patient respiratory tracts was positively linked to lung disease severity. ALB, LYM, LYM (%), LDH, NEU (%), and CRP were highly correlated to the acute lung injury. Age, viral load, lung injury score, and blood biochemistry indexes, albumin (ALB), CRP, LDH, LYM (%), LYM, and NEU (%), may be predictors of disease severity. Moreover, the Angiotensin II level in the plasma sample from 2019-nCoV infected patients was markedly elevated and linearly associated to viral load and lung injury. Our results suggest a number of potential diagnosis biomarkers and angiotensin receptor blocker (ARB) drugs for potential repurposing treatment of 2019-nCoV infection.

1 July 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
YYYang Yang
Yang Yang
CSChenguang Shen
Chenguang Shen
JLJinxiu Li
Jinxiu Li
JYJing Yuan
Jing Yuan
JWJinli Wei
Jinli Wei
YLYingxia Liu
Yingxia Liu

1 December 2016 in Cell Host & Microbe
Verified
Journal Article
Closed access
YBYuhai Bi
Yuhai Bi
QCQuanjiao Chen
Quanjiao Chen
QWQianli Wang
Qianli Wang
JCJianjun Chen
Jianjun Chen
TJTao Jin
Tao Jin
GGGeorge F. Fu Gao
George F. Fu Gao

12 February 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YYYang Yang
Yang Yang
MYMinghui Yang
Minghui Yang
CSChenguang Shen
Chenguang Shen
FWFuxiang Wang
Fuxiang Wang
JYJing Yuan
Jing Yuan
YLYingxia Liu
Yingxia Liu
Background: The outbreak of novel coronavirus pneumonia (NCP) caused by 2019-nCoV spread rapidly, and elucidating the diagnostic accuracy of different respiratory specimens is crucial for the control and treatment of this disease. Methods: Respiratory samples including nasal swabs, throat swabs, sputum and bronchoalveolar lavage fluid (BALF) were collected from Guangdong CDC confirmed NCP patients, and viral RNAs were detected using a CFDA approved detection kit. Results were analyzed in combination with sample collection date and clinical information. Findings: Except for BALF, the sputum possessed the highest positive rate (74.4%∼88.9%), followed by nasal swabs (53.6%∼73.3%) for both severe and mild cases during the first 14 days after illness onset (d.a.o). For samples collected ≥ 15 d.a.o, sputum and nasal swabs still possessed a high positive rate ranging from 42.9%∼61.1%. The positive rate of throat swabs collected ≥ 8 d.a.o was low, especially in samples from mild cases. Viral RNAs could be detected in all the lower respiratory tract of severe cases, but not the mild cases. CT scan of cases 02, 07 and 13 showed typical viral pneumonia with ground-glass opacity, while no viral RNAs were detected in first three or all the upper respiratory samples. Interpretation: Sputum is most accurate for laboratory diagnosis of NCP, followed by nasal swabs. Detection of viral RNAs in BLAF is necessary for diagnosis and monitoring of viruses in severe cases. CT scan could serve as an important make up for the diagnosis of NCP. Funding: National Science and Technology Major Project, Sanming Project of Medicine and China Postdoctoral Science Foundation.

6 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YYYang Yang
Yang Yang
CSChenguang Shen
Chenguang Shen
JLJinxiu Li
Jinxiu Li
JYJing Yuan
Jing Yuan
MYMinghui Yang
Minghui Yang
YLYingxia Liu
Yingxia Liu
The outbreak of Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, December 2019, and continuously poses a serious threat to public health. Our previous study has shown that cytokine storm occurred during SARS-CoV-2 infection, while the detailed role of cytokines in the disease severity and progression remained unclear due to the limited case number. In this study, we examined 48 cytokines in the plasma samples from 53 COVID-19 cases, among whom 34 were severe cases, and the others moderate. Results showed that 14 cytokines were significantly elevated upon admission in COVID-19 cases. Moreover, IP-10, MCP-3, and IL-1ra were significantly higher in severe cases, and highly associated with the PaO 2 /FaO 2 and Murray score. Furthermore, the three cytokines were independent predictors for the progression of COVID-19, and the combination of IP-10, MCP-3 and IL-1ra showed the biggest area under the curve (AUC) of the receiver-operating characteristics (ROC) calculations. Serial detection of IP-10, MCP-3 and IL-1ra in 14 severe cases showed that the continuous high levels of these cytokines were associated with disease deterioration and fatal outcome. In conclusion, we report biomarkers that closely associated with disease severity and outcome of COVID-19. These findings add to our understanding of the immunopathologic mechanisms of SARS-CoV-2 infection, providing novel therapeutic targets and strategy.